Weekly intramuscular injections of rotigotine extended-release microspheres are linked to significant symptom improvement in ...

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

New study uses state-of-the-art technology to examine link between gene mutation and neurodegenerative disease A University of Wollongong ...

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, ...

LAHORE: The Ministry of Planning, Development and Special Initiatives (PD&SI) has outlined a roadmap to accelerate the ...

About 90,000 individuals are diagnosed with Parkinson’s Disease (PD) in the United States each year. In the Philippines, ...

Camrelizumab and famitinib are projected to achieve global annual sales of $463 million and $108 million by 2031.

A new study led by Rice University's Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog the brain, associated with ...

There is zero doubt that the word on everyone’s lips right now is Artificial Intelligence (AI); adoption, the benefits and ...

A label expansion for Keytruda in platinum-resistant ovarian cancer would further entrench MSD’s dominance in the PD-1 space.